PRKAB1 and glucose metabolism disease: Therefore, the impairment of signaling pathways targeting AMPK/ACC can aggravate glucose metabolism disorder on the one hand, and lead to the accumulation of fatty acids and lipid metabolism abnormality on the other hand.